David A. Dodd and Kelly T McKee, Jr., MD, MPH Checkpoint inhibitors can only amplify an antitumor immune response that already exists, which is why immunologically “cold” tumors remain one of ...

Breast Cancer Awareness Month has evolved far beyond a public-health campaign. Over four decades, patient advocacy, philanthropy, data collection, molecular science, and increasingly sophisticated ...

In a market where biotech venture funding has rebounded sharply but investors are more selective, Chris Ehrlich, CEO of CERo Therapeutics, argues that capital strategy matters as much as scientific ...

Artificial intelligence (AI) is increasingly used in oncology to support tasks such as clinical-trial matching, evidence review, mammography, digital pathology, cancer biology, and drug discovery.

Diagnosis and patient communication account for about 60% of the trial set. These are the two largest categories by a wide margin, and they sit at opposite ends of the care pathway. Diagnostic ...

Breast cancer prevention remains an important opportunity to move care earlier in the disease continuum, particularly by addressing measurable risk factors such as mammographic breast density (MBD).

The application of ifinatamab deruxtecan sought accelerated approval for adults with ES-SCLC whose disease progressed on or after platinum-based chemotherapy. The FDA accepted it in April 2026 under ...

A new surface-applied brachytherapy device is expanding the treatment options available for selected patients with early-stage non-melanoma skin cancer. CivaDerm™ delivers palladium-103 radiation ...